MedTrace Logo

Bovine Atelocollagen Skin Sensitization Test

NCT05235087 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2024-08-01

No results posted yet for this study

Summary

Bovine atelocollagen skin testing of healthy adult volunteers to investigate the potential of allergy to atelocollagen medical device implants

Conditions

  • Healthy

Interventions

DEVICE

Bovine atelocollagen intradermal injection

Intradermal skin test injection

Sponsors & Collaborators

  • AscentX Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Peter Rullan, MD · Dermatology Institute

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2023-11-01
Completion
2023-12-01
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05235087 on ClinicalTrials.gov